SGEM#484: The Warrior – Pharmacological Interventions for the Acute Treatment of Hyperkalemia

Acute hyperkalemia management requires balancing rapid pharmacological intervention with patient safety. A recent systematic review and meta-analysis indicates that insulin combined with glucose and sodium zirconium cyclosilicate effectively lower serum potassium levels within four hours. Conversely, common treatments like bicarbonate and calcium gluconate lack evidence for reducing potassium, though calcium remains essential for cardiac membrane stabilization. Significant methodological heterogeneity and the prevalence of low-quality primary studies undermine definitive conclusions regarding optimal treatment protocols. Furthermore, findings from specialized hospital units may not fully translate to the high-acuity, time-sensitive environment of the emergency department. Clinicians should prioritize insulin-glucose regimens while integrating newer agents cautiously, recognizing that current evidence remains insufficient to abandon established stabilization practices. William Toon, a veteran paramedic and educator, provides expert perspective on applying these findings within the chaotic, real-world constraints of pre-hospital and emergency care.